Sobi plans to publish its report for the fourth quarter and full year of 2023 on 8 February 2024 at 08:00 CET.
Investors, analysts, and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the same day at 14:00 CET, 13:00 pm GMT, and 8:00 am EDT.
The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call.
To participate in the conference call, please use the following dial-in details:
Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across Europe, North America, the Middle East, Asia and Australia. In 2022, revenue amounted to SEK 18.8 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com, LinkedIn and YouTube.
Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.
Integral Consulting continues to invest in its people and expand across practice areas to meet increasing demands of legal, industrial, and government clients. With five new Principals recently added to our team, we further our commitment to address...
Sage Growth Partners (SGP), a healthcare growth strategy and marketing firm, today announced the completion of a comprehensive brand refresh, showcasing a new logo and website that underscore the company's expanding influence, client roster, and...
Leaders from two of New York's preeminent bioscience and healthcare institutions came together at Carnegie Hall to acknowledge the signing of an update to their affiliation agreement initiated in 2015. The Cold Spring Harbor Laboratory-Northwell...
Standard Process, a leading whole food-based nutritional supplement company based in Wisconsin, has earned the 2024 Top Workplaces USA Award, issued by Energage. The company has also been named a Southeast Wisconsin Top Workplace by The Milwaukee...
BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric solution for urge urinary incontinence (UUI), announced today that the Revi System, a minimally invasive therapy, is now...
Agile Consulting Group, Inc., a leading national sales and use tax consulting firm, today announced it has partnered with The Rural Collaborative to deliver Agile's innovative sales and use tax consulting services to The Rural Collaborative's...